United Medical Equipment Business Solutions Network distributes rapid antigen tests and comprehensive telehealth solutions that allow providers to work more proficiently, health-care systems to work smarter and patients to live healthier lives. Through the provision of COVID-19 rapid kit testing, UME is helping to maintain safety and health during a global pandemic.
Rapid antigen testing provides critical answers and insight to health-care and essential workers as they continue to come into contact with potential cases daily, monitoring their day-to-day health becomes crucial. Symptoms present differently with some individuals being asymptomatic. Having access to rapid kits allows facilities to develop a standard for monitoring health and lowering the spread of COVID in the workplace and larger community.
Even with the expanding vaccination program, the United States is still far from herd immunity. Herd immunity happens when the majority of people in the community have had the vaccine, allowing those who are unable to be vaccinated also to be protected. To move forward and away from the current health pandemic, 50% to 90% of the population needs to be vaccinated. The large gap in the percentage is because the virus is still relatively new and more data needs to be collected. The most recent reporting states that it is closer to 90% who need to receive the vaccine to reach this goal (https://ibn.fm/eaLjM).
While the United States is eagerly promoting vaccination, there are several reasons why herd immunity is a moving target. This includes varying beliefs around vaccinations throughout the country, the emergence of new variants of SAR-CoV-2 and accessibility of the vaccine.
In the meantime, rapid testing kits provide fast answers. Facilities can set up monthly tests as well as testing when exposure is suspected. Rapid tests also increase the safety of travel. Many are taking tests before domestic flights. Doing so helps remove the virus from the environment, ensuring the safety of fellow travelers.
According to the CDC’s website, “the incubation period (the time from exposure to development of symptoms) of SARS-CoV-2 and other coronaviruses (e.g., MERS-CoV, SARS-CoV) ranges from 2-14 days” (https://ibn.fm/6aOAM). This means an individual could be contagious before actually knowing they have been exposed. Rapid testing kits are the answer. They identify the virus quickly, eliminating the need to quarantine while waiting for the results and allowing vital personnel to get back to work.
From the beginning of the pandemic, UME moved quickly to address the unique testing needs created by COVID-19. The company acted as a trusted senior referral source for senior care living communities such as independent and assisted living, hospice and memory care. In addition to being a trusted supplier of FDA-approved COVID-19 rapid kits, UME also supplied personal protective equipment (“PPE”) with flexible payment options and provided comprehensive telehealth solutions.
UME has been and continues to be committed to addressing the demand of essential resources during today’s global pandemic climate.
For more information, visit the company’s websites at www.UnitedMedSolutions.com www.MedicationManagement.app.
NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Designations granted by leading global regulatory agencies play a critical role in advancing drug-development programs.…
Enormous resources are being channeled into studying different ways to support the immune system in its fight…
Recent research shows how chemotherapy and immunotherapy can complement each other when used together. Within…
David Eby, the Premier of British Columbia, has revealed that a wide range of American healthcare workers,…
Patients increasingly prefer access, speed and convenience, but healthcare systems also need better coordination, safer…
High-quality development platforms and translational research frameworks have become essential tools in rare-disease biotechnology. Soligenix…